MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q3
hinzugefügt 06.11.2025
Pacira BioSciences Langfristiger Schuldenstrom 2011-2026 | PCRX
Langfristiger Schuldenstrom Jährlich Pacira BioSciences
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8.89 M | 8.8 M | 9.12 M | 7.89 M | 7.42 M | 4.94 M | - | - | - | 119 M | 120 M | 120 M | - | 7.04 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 120 M | 4.94 M | 41.3 M |
Langfristiger Schuldenstrom anderer Aktien in der Arzneimittelhersteller
| Name | Langfristiger Schuldenstrom | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Aerie Pharmaceuticals
AERI
|
4.36 M | - | - | $ 754 M |  USA |
 |
AcelRx Pharmaceuticals
ACRX
|
5.36 M | - | 7.5 % | $ 6.35 M | USA |
 |
Catalent
CTLT
|
13 M | - | - | $ 11.5 B | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
343 K | - | 0.86 % | $ 117 M | USA |
 |
DURECT Corporation
DRRX
|
1.38 M | - | - | $ 50.1 M | USA |
 |
Endo International plc
ENDP
|
956 K | - | - | $ 28.9 M |  Irlanda |
 |
Agile Therapeutics
AGRX
|
366 K | - | 10.11 % | $ 58.2 M | USA |
 |
Canopy Growth Corporation
CGC
|
7.46 M | $ 1.1 | 2.84 % | $ 118 M |  Canada |
 |
Evoke Pharma
EVOK
|
13.4 K | - | - | $ 36.6 M | USA |
 |
Alimera Sciences
ALIM
|
634 K | - | - | $ 142 M | USA |
 |
Evolus
EOLS
|
2.53 M | $ 5.68 | 37.53 % | $ 366 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
582 K | - | - | $ 2.06 B |  France |
 |
Jupiter Wellness
JUPW
|
213 K | - | - | $ 33.6 M | USA |
 |
China Pharma Holdings
CPHI
|
39.3 K | $ 0.59 | 6.08 % | $ 10.3 M |  China |
 |
Cumberland Pharmaceuticals
CPIX
|
357 K | $ 3.81 | -16.81 % | $ 53.6 M | USA |
 |
Calliditas Therapeutics AB (publ)
CALT
|
3.91 M | - | -0.1 % | $ 2.03 B |  Schweden |
 |
HEXO Corp.
HEXO
|
914 K | - | 2.45 % | $ 38.1 M | Canada |
 |
Harrow Health
HROW
|
887 K | $ 40.02 | 3.65 % | $ 1.47 B | USA |
 |
Neoleukin Therapeutics
NLTX
|
2.56 M | - | - | $ 193 M | Canada |
 |
Aurora Cannabis
ACB
|
5.38 M | $ 3.65 | 4.89 % | $ 86.3 M | Canada |
 |
Athenex
ATNX
|
2.09 M | - | -23.39 % | $ 1.76 M | USA |
 |
Emergent BioSolutions
EBS
|
3.5 M | $ 8.95 | 0.39 % | $ 458 M | USA |
 |
ProPhase Labs
PRPH
|
301 K | - | - | $ 5.07 M | USA |
 |
Assertio Holdings
ASRT
|
928 K | $ 12.19 | 2.48 % | $ 866 M | USA |
 |
Radius Health
RDUS
|
613 K | - | - | $ 1.42 B | USA |
 |
Bausch Health Companies
BHC
|
61 M | $ 5.67 | -0.87 % | $ 2.07 B | Canada |
 |
Lannett Company
LCI
|
2.06 M | - | 1.15 % | $ 7.11 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
1.53 M | - | -39.89 % | $ 27.7 M | USA |
 |
Organogenesis Holdings
ORGO
|
4.27 M | $ 2.87 | 0.01 % | $ 378 M | USA |
 |
OrganiGram Holdings
OGI
|
1.03 M | $ 1.4 | 2.19 % | $ 402 M | Canada |
 |
Rockwell Medical
RMTI
|
1.38 M | $ 0.91 | 1.03 % | $ 21.2 M | USA |
 |
Perrigo Company plc
PRGO
|
25.7 M | $ 11.71 | 2.81 % | $ 1.62 B | USA |
 |
Sundial Growers
SNDL
|
34.3 M | $ 1.55 | 1.21 % | $ 3.37 M | Canada |
 |
TherapeuticsMD
TXMD
|
1.47 M | $ 2.25 | 1.35 % | $ 23.5 M | USA |
 |
Veru
VERU
|
1.07 M | $ 2.53 | 0.4 % | $ 341 M | USA |
 |
Viatris
VTRS
|
80.6 M | $ 14.74 | -1.04 % | $ 17.7 B | USA |
 |
PetIQ
PETQ
|
7.61 M | - | 1.64 % | $ 400 M | USA |
 |
OptiNose
OPTN
|
911 K | - | - | $ 1.08 B | USA |
 |
PLx Pharma
PLXP
|
622 K | - | -27.8 % | $ 2.56 M | USA |
 |
Recro Pharma
REPH
|
1.1 M | - | -4.76 % | $ 65.3 M | USA |
 |
cbdMD
YCBD
|
98.7 K | $ 0.75 | -2.76 % | $ 3.23 M | USA |
 |
SCYNEXIS
SCYX
|
340 K | $ 0.76 | 1.22 % | $ 36.4 M | USA |
 |
Solid Biosciences
SLDB
|
1.79 M | $ 6.14 | 3.02 % | $ 251 M | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
58 K | $ 2.74 | -0.36 % | $ 3.4 M | USA |
 |
Tricida
TCDA
|
2.74 M | - | - | $ 3.25 M | USA |
 |
Tilray
TLRY
|
2.47 M | $ 7.33 | -0.48 % | $ 4.53 B | Canada |
 |
Zynerba Pharmaceuticals
ZYNE
|
215 K | - | - | $ 55.5 M | USA |